Preclinical Evaluation of Brigimadlin (BI 907828) As a Novel MDM2 Inhibitor in Acute Lymphoblastic Leukemia


APTULLAHOĞLU E.

Black Sea Journal of Engineering and Science, cilt.8, sa.5, ss.1450-1459, 2025 (Hakemli Dergi)